Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.65 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.65 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.65 |
| ▸ | CTSB | P07858 | 1/20 | 0.62 |
| ▸ | MME | P08473 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5966405 | 1.00 | OPRM1 (0.65) | OPRM1OPRD1OPRK1CTSBMME | |
| SCHEMBL31754371 | 0.95 | OPRD1 (0.62) | OPRM1OPRD1OPRK1CTSBMME | |
| SCHEMBL29789592 | 0.95 | CTSB (0.64) | OPRM1OPRD1OPRK1CTSBMME | |
| SCHEMBL29746506 | 0.95 | OPRM1 (0.60) | OPRM1OPRD1OPRK1CTSBMME | |
| SCHEMBL9829182 | 0.92 | MME (0.64) | OPRM1OPRD1OPRK1MME | |
| SCHEMBL9551455 | 0.92 | MME (0.64) | OPRM1OPRD1OPRK1MME | |
| SCHEMBL5370772 | 0.92 | MME (0.64) | OPRM1OPRD1OPRK1MME | |
| SCHEMBL8983313 | 0.91 | CTSB (0.62) | OPRM1OPRD1OPRK1CTSBMME | |
| SCHEMBL8983297 | 0.91 | CTSB (0.62) | OPRM1OPRD1OPRK1CTSBMME | |
| SCHEMBL23142822 | 0.91 | CTSB (0.55) | OPRM1OPRD1OPRK1CTSBMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4682156-A1 | LINKER AND DRUG CONJUGATE USING SAME, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF | Shanghai Affinity Biopharmaceutical Co., Ltd. (CN) | 2026-01-21 | — | — | EP | disclosed |
| CN-118666946-A | Connector, coupling drug using same, antibody coupling drug and application of antibody coupling drug | 上海亲合力生物医药科技股份有限公司 | 2024-09-20 | — | — | CN | disclosed |
| WO-2024188314-A1 | LINKER AND DRUG CONJUGATE USING SAME, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF | 上海亲合力生物医药科技股份有限公司 | 2024-09-19 | — | — | WO | disclosed |
| CN-220176828-U | Microchannel reaction device for synthesizing polypeptide | 厦门胜泽泰医药科技有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-116589531-A | Microchannel reaction device for synthesizing polypeptide and leucine enkephalin cyclic synthesis process | 厦门胜泽泰医药科技有限公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-115747058-A | Micro-fluidic chip, detection system and surface treatment reagent combination therein | 上海柏慧康生物科技有限公司 | 2023-03-07 | — | — | CN | disclosed |
| US-7560286-B2 | Mass spectrometric method for structural analysis of chain nitrogen-containing compounds using sqauric acid | SUNTORY HOLDINGS LIMITED (JP) | 2009-07-14 | — | — | US | disclosed |
| US-7560286-B2 | Mass spectrometric method for structural analysis of chain nitrogen-containing compounds using sqauric acid | SUNTORY HOLDINGS LIMITED (JP) | 2009-07-14 | — | — | US | disclosed |
| US-20060275900-A1 | Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells | BECTON, DICKINSON AND COMPANY (US) | 2006-12-07 | — | — | US | disclosed |
| US-20060122104-A1 | Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells | BECTON, DICKINSON AND COMPANY | 2006-06-08 | — | — | US | disclosed |
| EP-0804246-B1 | DRUG DELIVERY AGENTS INCORPORATING MITOMYCIN | EUROP ECONOMIC COMMUNITY (LU) | 2000-05-17 | — | — | EP | disclosed |
| EP-0804246-A1 | DRUG DELIVERY AGENTS INCORPORATING MITOMYCIN | Commission of the European Communities (LU) | 1997-11-05 | — | — | EP | disclosed |
| EP-0432022-B1 | Medium for reaction and dissolution of peptides and process of peptide synthesis by making use of said medium | RHONE POULENC CHIMIE (FR) | 1996-10-23 | — | — | EP | disclosed |
| WO-1995005200-A1 | DRUG DELIVERY AGENTS INCORPORATING MITOMYCIN | EUROPEAN COMMUNITY (LU) | 1995-02-23 | — | — | WO | disclosed |
| EP-0421848-B1 | Process to stabilise peptides and process to synthetise peptides | RHONE POULENC CHIMIE (FR) | 1995-02-08 | — | — | EP | disclosed |
| EP-0432022-A1 | Medium for reaction and dissolution of peptides and process of peptide synthesis by making use of said medium | RHONE-POULENC CHIMIE (FR) | 1991-06-12 | — | — | EP | disclosed |
| EP-0421848-A1 | Process to stabilise peptides and process to synthetise peptides | RHONE-POULENC CHIMIE (FR) | 1991-04-10 | — | — | EP | disclosed |